Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Structure Therapeutics IncADRS | 1,502,747 | 2,109,584 | +606,837 | $75.77M | $85.99M | 9.54% | +$10.22M |
| Inhibrx,incCOMM | 1,750,387 | 1,750,387 | 0 | $32.12M | $66.51M | 7.38% | +$34.40M |
| Icosavax IncCOMM | 3,703,704 | 3,703,704 | 0 | $28.70M | $58.37M | 6.47% | +$29.67M |
| AN2 Therapeutics, Inc.COMM | 2,678,209 | 2,678,209 | 0 | $43.07M | $54.88M | 6.09% | +$11.81M |
| Rayzebio, Inc.COMM | 869,908 | 869,908 | 0 | $19.31M | $54.08M | 6.00% | +$34.77M |
| Aerovate Therapeutics IncCOMM | 2,201,274 | 2,201,274 | 0 | $29.87M | $49.81M | 5.52% | +$19.94M |
| Geron CorporationCOMM(GERN) | 23,375,839 | 23,375,839 | 0 | $49.56M | $49.32M | 5.47% | -$233.8K |
| Savara Inc.COMM(SVRA) | 10,000,000 | 10,000,000 | 0 | $37.80M | $47.00M | 5.21% | +$9.20M |
| Gracell Biotechnologies Inc.ADRS | 3,038,889 | 4,514,786 | +1,475,897 | $8.75M | $45.33M | 5.03% | +$36.58M |
| Madrigal Pharmaceuticals, Inc.COMM(MDGL) | 179,917 | 179,917 | 0 | $26.28M | $41.63M | 4.62% | +$15.35M |
| Kalvista Pharmaceuticals, IncCOMM | 3,395,495 | 3,395,495 | 0 | $32.70M | $41.59M | 4.61% | +$8.90M |
| Silence Therapeutics plcADRS(SLN) | 2,104,875 | 2,104,875 | 0 | $20.67M | $36.56M | 4.05% | +$15.89M |
| COMPASS Pathways plcADRS(CMPS) | 3,858,000 | 3,858,000 | 0 | $28.55M | $33.76M | 3.74% | +$5.21M |
| Cogent Biosciences, Inc.COMM(COGT) | 5,631,042 | 5,631,042 | 0 | $54.90M | $33.11M | 3.67% | -$21.79M |
| Tyra Biosciences, Inc.COMM(TYRA) | 1,989,103 | 1,989,103 | 0 | $27.39M | $27.55M | 3.06% | +$159.1K |
| Tourmaline Bio IncCOMM | 0 | 1,007,902 | +1,007,902 | $0 | $26.39M | 2.93% | +$26.39M |
| Tarsus Pharmaceuticals, Inc.COMM(TARS) | 1,142,857 | 1,142,857 | 0 | $20.31M | $23.14M | 2.57% | +$2.83M |
| Dyne Therapeutics, Inc.COMM(DYN) | 1,650,150 | 1,650,150 | 0 | $14.79M | $21.95M | 2.43% | +$7.16M |
| Kura Oncology, Inc.COMM(KURA) | 1,423,642 | 1,423,642 | 0 | $12.98M | $20.47M | 2.27% | +$7.49M |
| Centessa Pharmaceuticals PlcCOMM | 2,040,816 | 2,040,816 | 0 | $13.20M | $16.24M | 1.80% | +$3.04M |
| Vistagen Therapeutics, Inc.COMM(VTGN) | 0 | 2,676,580 | +2,676,580 | $0 | $13.76M | 1.53% | +$13.76M |
| ABIVAX Société AnonymeCOMM(ABVX) | 0 | 1,100,000 | +1,100,000 | $0 | $11.77M | 1.31% | +$11.77M |
| Cabaletta Bio, Inc.COMM(CABA) | 486,795 | 486,795 | 0 | $7.41M | $11.05M | 1.23% | +$3.64M |
| Entrada Therapeutics, Inc.COMM(TRDA) | 584,955 | 584,955 | 0 | $9.24M | $8.83M | 0.98% | -$415.3K |
| Nurix Therapeutics, Inc.COMM(NRIX) | 0 | 717,654 | +717,654 | $0 | $7.41M | 0.82% | +$7.41M |
| C4 Therapeutics, Inc.COMM(CCCC) | 1,276,574 | 1,276,574 | 0 | $2.37M | $7.21M | 0.80% | +$4.84M |
| Taysha Gene Therapies, Inc.COMM(TSHA) | 11,111,111 | 2,912,861 | -8,198,250 | $35.11M | $5.16M | 0.57% | -$29.96M |
| Ventyx Biosciences, IncCOMM | 815,724 | 815,724 | 0 | $28.33M | $2.01M | 0.22% | -$26.32M |
| Kodiak Sciences Inc.COMM(KOD) | 0 | 267,941 | +267,941 | $0 | $814.5K | 0.09% | +$814.5K |
| IMMUNOVANT, INCCOMM(IMVT) | 334,853 | 0 | -334,853 | $12.86M | $0 | — | -$12.86M |
| MERUS N.V.COMM | 300,000 | 0 | -300,000 | $7.07M | $0 | — | -$7.07M |